Sabrina Arena

Wild-Type <i>BRAF</i> Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer

Federica Di Nicolantonio, Miriam Martini, Francesca Molinari et al. · Journal of Clinical Oncology · 2008 · 1.6K citations · Full text

Kras Mutations, Gastrointestinal Oncology, Medicine +13

Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab

Wendy De Roock, Derek J. Jonker, Federica Di Nicolantonio et al. · JAMA · 2010 · 743 citations

EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer

Vito Amodio, Rona Yaeger, Pamela Arcella et al. · Cancer Discovery · 2020 · 443 citations · Full text

Adaptive mutability of colorectal cancers in response to targeted therapies

Mariangela Russo, Giovanni Crisafulli, Alberto Sogari et al. · Science · 2019 · 425 citations · Full text

Pathology, Cancer Biology, Tumor Biology +16

Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimus

Federica Di Nicolantonio, Sabrina Arena, Josep Tabernero et al. · Journal of Clinical Investigation · 2010 · 343 citations · Full text

Cancer Biology, Cellular Physiology, Tumor Biology +16